Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | DGKA | P23743 | 2/20 | 0.62 |
| ▸ | PAM | P19021 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 5/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.49 |
| ▸ | PRKCA | P17252 | 1/20 | 0.47 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.47 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.47 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Allyl Decanoate SCHEMBL436741 | 1.00 | TSHR (1.00) | TSHRDGKAPAMLMNAMAPT | |
| SCHEMBL439396 | 1.00 | TSHR (1.00) | TSHRDGKAPAMLMNAMAPT | |
| Hexadecanoic Acid Allyl Ester SCHEMBL370895 | 1.00 | TSHR (1.00) | TSHRDGKAPAMLMNAMAPT | |
| SCHEMBL3503097 | 1.00 | TSHR (1.00) | TSHRDGKAPAMLMNAMAPT | |
| Allyl Octanoate SCHEMBL126629 | 1.00 | TSHR (1.00) | TSHRDGKAPAMLMNAMAPT | |
| Allyl Heptanoate SCHEMBL4147097 | 1.00 | TSHR (1.00) | TSHRDGKAPAMLMNAMAPT | |
| Allyl Heptanoate SCHEMBL20820 | 1.00 | TSHR (1.00) | TSHRDGKAPAMLMNAMAPT | |
| SCHEMBL440501 | 1.00 | TSHR (1.00) | TSHRDGKAPAMLMNAMAPT | |
| SCHEMBL19133353 | 1.00 | TSHR (1.00) | TSHRDGKAPAMLMNAMAPT | |
| SCHEMBL1176823 | 1.00 | TSHR (1.00) | TSHRDGKAPAMLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118562040-A | Functionalized fluorinated copolymer and preparation method and application thereof | 上海华谊三爱富新材料有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-114507312-A | Interface modified viscosity reducer for oil displacement and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-05-17 | — | — | CN | claimed |
| CN-113278608-A | Chloroform substitute reagent for nucleic acid extraction and separation | 杭州新景生物试剂开发有限公司 | 2021-08-20 | — | — | CN | claimed |
| CN-107987749-B | Tackifier, tackifier composition and preparation method of tackifier | 东莞市贝特利新材料有限公司 | 2020-08-18 | — | — | CN | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| US-8298327-B2 | Hot melt inks | MARKEM-IMAJE CORPORATION (US) | 2012-10-30 | — | — | US | claimed |
| JP-4739231-B2 | — | — | 2011-08-03 | — | — | JP | claimed |
| EP-1716159-B1 | BICYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | MOMENTIVE PERFORMANCE MAT INC (US) | 2011-07-13 | — | — | EP | claimed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | claimed |
| US-7578874-B2 | Marking foods; heating to liquefy, transferring to substrate | MARKEM CORPORATION (US) | 2009-08-25 | — | — | US | claimed |
| EP-1716159-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | General Electronic Company (US) | 2006-11-02 | — | — | EP | claimed |
| EP-1697386-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | General Electric Company A Corporation of the State of New York (US) | 2006-09-06 | — | — | EP | claimed |
| WO-2005066187-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050158434-A1 | Hot melt inks | MARKEM-IMAJE CORPORATION | 2005-07-21 | — | — | US | claimed |
| WO-2005066186-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20030036489-A1 | Consumable composition comprising perfumed particles and article containing the same | THE PROCTER & GAMBLE COMPANY | 2003-02-20 | — | — | US | claimed |
| WO-2002090479-A1 | PERFUMED PARTICLES AND ARTICLES CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| WO-2002090481-A1 | COMPOSITIONS AND ARTICLES FOR EFFECTIVE DEPOSITION OF PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | F9, RPL39, ECPAS | TSHR 4528/4885DGKA 3675/4885PAM 2250/4885 |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | F9, RPL39, ALDH16A1 | TSHR 4168/4885DGKA 3785/4885PAM 1660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.